KAMAS

Automating the detection and tracking of movement disorders using the Microsoft Kinect.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Employees 3
  • Website motionassessment.com

Company Summary

Tracking involuntary movement disorders is notoriously difficult for doctors. Tests for these disorders are subjective and difficult to perform reliably. KAMAS's goal is to provide simple, cheap, accessible technology that can automate the performance of these tests in the patient's home.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free